Towa Pharmaceutical Co Ltd 2025 Integrated Report
Company: Towa Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Integrated Report
Pages: 62
The report highlights FY2024 consolidated net sales of JPY 259,594 million and group-wide environmental inputs including 36,051 kl of energy and 792,675 m3 of water. It reports FY2024 Scope 1, 2, and 3 emissions of 30,077, 28,353, and 1,066,500 tCO2, respectively, alongside a 30% reduction target for Scopes 1 and 2 by FY2030. The report also describes completion of the 17.5 billion-tablet annual production system and the 2025 launch of the Rivaluen LA Patch.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.